QSC Tirzepatide is a novel dual receptor agonist targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This peptide compound has shown potential in weight management applications through its ability to delay gastric emptying and suppress appetite.
The product is supplied as a white powder with high purity (99%) and is packaged in vials of various sizes to meet different research requirements. Each batch undergoes strict quality control to ensure consistency and reliability for research applications.
As a research chemical, QSC Tirzepatide is intended for laboratory use only and not for human consumption. Researchers should handle this material with appropriate safety precautions in controlled laboratory environments.
The product demonstrates stability when stored properly in a closed container under cool, dry conditions (below 5°C). With a molecular weight of 4813 Da and molecular formula C225H348N48O68, QSC Tirzepatide offers researchers a valuable tool for metabolic studies.